240 related articles for article (PubMed ID: 24890812)
21. Lymphatic vessel density in primary melanomas predicts sentinel lymph node status and risk of metastasis.
Shayan R; Karnezis T; Murali R; Wilmott JS; Ashton MW; Taylor GI; Thompson JF; Hersey P; Achen MG; Scolyer RA; Stacker SA
Histopathology; 2012 Oct; 61(4):702-10. PubMed ID: 22734806
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous melanoma in the elderly.
Testori A; Soteldo J; Sances D; Mazzarol G; Trifirò G; Zonta M; Rastrelli M; Schenone F; Verrecchia F
Melanoma Res; 2009 Jun; 19(3):125-34. PubMed ID: 19381113
[TBL] [Abstract][Full Text] [Related]
23. Subungual melanoma: diagnosis and management.
Woods CC; Bacon LN; Ballard BR; Beech DJ
Tenn Med; 2012 Feb; 105(2):35-7, 42. PubMed ID: 22375439
[TBL] [Abstract][Full Text] [Related]
24. Lymph-node metastases in patients with melanoma: what is the optimum management?
Fife K; Thompson JF
Lancet Oncol; 2001 Oct; 2(10):614-21. PubMed ID: 11902552
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and management of stage I/II melanoma.
Lamb LA; Halpern AC; Hwu WJ
Semin Oncol Nurs; 2003 Feb; 19(1):22-31. PubMed ID: 12638378
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous melanoma.
Thompson JF; Scolyer RA; Kefford RF
Lancet; 2005 Feb 19-25; 365(9460):687-701. PubMed ID: 15721476
[TBL] [Abstract][Full Text] [Related]
27. [Diagnosis, pathology and therapy of malignant melanoma of the skin (author's transl)].
Kerl H
Wien Klin Wochenschr; 1976 Jun; 88(12):369-79. PubMed ID: 782045
[TBL] [Abstract][Full Text] [Related]
28. Peritumoral D2-40 Chalkley score independently predicts metastases and survival in patients with cutaneous malignant melanoma.
Pastushenko I; Vermeulen PB; Vicente-Arregui S; Van den Eynden GG; Alvarez-Alegret R; Querol I; Rutten A; Carapeto FJ; Dirix LY; Van Laere S
J Cutan Pathol; 2015 Oct; 42(10):699-711. PubMed ID: 26264662
[TBL] [Abstract][Full Text] [Related]
29. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
30. The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status.
Sahni D; Robson A; Orchard G; Szydlo R; Evans AV; Russell-Jones R
J Clin Pathol; 2005 Jul; 58(7):715-21. PubMed ID: 15976338
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node excision and positron emission tomography and computed tomography in the initial stage of malignant melanoma.
Hafner J
Dermatol Surg; 2010 Dec; 36(12):2082-3. PubMed ID: 21126282
[No Abstract] [Full Text] [Related]
32. Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanoma.
Tejera-Vaquerizo A; Nagore E; Puig S; Robert C; Saiag P; Martín-Cuevas P; Gallego E; Herrera-Acosta E; Aguilera J; Malvehy J; Carrera C; Cavalcanti A; Rull R; Vilalta-Solsona A; Lannoy E; Boutros C; Benannoune N; Tomasic G; Aegerte P; Vidal-Sicart S; Palou J; Alos LL; Requena C; Traves V; Pla Á; Bolumar I; Soriano V; Guillén C; Herrera-Ceballos E
Eur J Cancer; 2015 Sep; 51(13):1780-93. PubMed ID: 26072362
[TBL] [Abstract][Full Text] [Related]
33. [Viewpoint of the Dutch Melanoma Working Group regarding sentinel lymph node biopsy: prognostic but not therapeutic implications].
Kruit WH;
Ned Tijdschr Geneeskd; 2008 Mar; 152(10):574-6. PubMed ID: 18402325
[TBL] [Abstract][Full Text] [Related]
34. Identification, clinical significance, and management of very small melanoma metastases in sentinel lymph nodes.
Cochran AJ
Ann Surg Oncol; 2015 Sep; 22(9):2812-4. PubMed ID: 26014157
[No Abstract] [Full Text] [Related]
35. Sentinel lymph nodes in cutaneous melanoma.
Prieto VG
Clin Lab Med; 2011 Jun; 31(2):301-10. PubMed ID: 21549243
[TBL] [Abstract][Full Text] [Related]
36. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
[TBL] [Abstract][Full Text] [Related]
37. [The latest diagnostical methods and therapy in melanoma].
Wojas-Pelc A; Rajzer L; Jaworek A; Woźniak W
Przegl Lek; 2006; 63(8):674-80. PubMed ID: 17441381
[TBL] [Abstract][Full Text] [Related]
38. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Hartgrink HH; Van de Velde CJ
Ned Tijdschr Geneeskd; 2004 Jun; 148(26):1311-2; author reply 1312. PubMed ID: 15279220
[No Abstract] [Full Text] [Related]
39. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
40. Sentinel lymph node status in melanoma: prognostic value in a tertiary hospital and correlation with mitotic activity.
Mahiques Santos L; Oliver Martinez V; Alegre de Miquel V
Actas Dermosifiliogr; 2014; 105(1):60-8. PubMed ID: 24021663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
